Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Santiswarup Singha

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
European Journal of Immunology|May 29, 2025
Inhibition of Melanoma Growth by Ex Vivo Expanded Tumor-Specific CD8+ T Cells Is Dependent on the Configuration of Nanoscale Artificial APCsAntara Mondal, Faisal Jamal, Arpita Das, et al.
Nature Communications|May 16, 2019
Suppression of a broad spectrum of liver autoimmune pathologies by single peptide-MHC-based nanomedicinesChannakeshava Sokke Umeshappa, Santiswarup Singha, Jesus Blanco, et al.
Plos One|October 1, 2019
In vivo clearance of nanoparticles by transcytosis across alveolar epithelial cellsPascal Detampel, Anutosh Ganguly, Sara Tehranian, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 2, 2021
Extremely short bioavailability and fast pharmacodynamic effects of pMHC-based nanomedicinesYang Yang, Kristofor K Ellestad, Santiswarup Singha, et al.
Nano Letters|June 24, 2025
Defining the Critical Valency of Peptide-MHC on Nanoscale Artificial Antigen Presenting Cells for Expanding Endogenous Tumor-Specific T-cells <i>In Vivo</i>Arnab Kumar Sahoo, Antara Mondal, Faisal Jamal, et al.
The Journal of Clinical Investigation|March 4, 2020
Ubiquitous antigen-specific T regulatory type 1 cells variably suppress hepatic and extrahepatic autoimmunityChannakeshava Sokke Umeshappa, Jacques Mbongue, Santiswarup Singha, et al.
Nature Communications|October 31, 2019
Increased yields and biological potency of knob-into-hole-based soluble MHC class II moleculesPau Serra, Nahir Garabatos, Santiswarup Singha, et al.
Nature Communications|June 7, 2022
Re-programming mouse liver-resident invariant natural killer T cells for suppressing hepatic and diabetogenic autoimmunityChannakeshava Sokke Umeshappa, Patricia Solé, Jun Yamanouchi, et al.
Cellular & Molecular Immunology|March 27, 2023
A T follicular helper cell origin for T regulatory type 1 cellsPatricia Solé, Jun Yamanouchi, Josep Garnica, et al.
Cell Reports|March 31, 2021
Liver-specific T regulatory type-1 cells program local neutrophils to suppress hepatic autoimmunity via CRAMPChannakeshava Sokke Umeshappa, Patricia Solé, Bas G J Surewaard, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
European Journal of Immunology|May 29, 2025
Inhibition of Melanoma Growth by Ex Vivo Expanded Tumor-Specific CD8+ T Cells Is Dependent on the Configuration of Nanoscale Artificial APCsAntara Mondal, Faisal Jamal, Arpita Das, et al.
Nature Communications|May 16, 2019
Suppression of a broad spectrum of liver autoimmune pathologies by single peptide-MHC-based nanomedicinesChannakeshava Sokke Umeshappa, Santiswarup Singha, Jesus Blanco, et al.
Plos One|October 1, 2019
In vivo clearance of nanoparticles by transcytosis across alveolar epithelial cellsPascal Detampel, Anutosh Ganguly, Sara Tehranian, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 2, 2021
Extremely short bioavailability and fast pharmacodynamic effects of pMHC-based nanomedicinesYang Yang, Kristofor K Ellestad, Santiswarup Singha, et al.
Nano Letters|June 24, 2025
Defining the Critical Valency of Peptide-MHC on Nanoscale Artificial Antigen Presenting Cells for Expanding Endogenous Tumor-Specific T-cells <i>In Vivo</i>Arnab Kumar Sahoo, Antara Mondal, Faisal Jamal, et al.
The Journal of Clinical Investigation|March 4, 2020
Ubiquitous antigen-specific T regulatory type 1 cells variably suppress hepatic and extrahepatic autoimmunityChannakeshava Sokke Umeshappa, Jacques Mbongue, Santiswarup Singha, et al.
Nature Communications|October 31, 2019
Increased yields and biological potency of knob-into-hole-based soluble MHC class II moleculesPau Serra, Nahir Garabatos, Santiswarup Singha, et al.
Nature Communications|June 7, 2022
Re-programming mouse liver-resident invariant natural killer T cells for suppressing hepatic and diabetogenic autoimmunityChannakeshava Sokke Umeshappa, Patricia Solé, Jun Yamanouchi, et al.
Cellular & Molecular Immunology|March 27, 2023
A T follicular helper cell origin for T regulatory type 1 cellsPatricia Solé, Jun Yamanouchi, Josep Garnica, et al.
Cell Reports|March 31, 2021
Liver-specific T regulatory type-1 cells program local neutrophils to suppress hepatic autoimmunity via CRAMPChannakeshava Sokke Umeshappa, Patricia Solé, Bas G J Surewaard, et al.
Pageof 3